Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Daoussis et al.
Rheumatology (Oxford) 2009;0:kep093v1-kep093.
ABSTRACT
| FULL TEXT
The Minimally Important Difference for the Health Assessment Questionnaire in Rheumatoid Arthritis Clinical Practice Is Smaller Than in Randomized Controlled Trials
POPE et al.
The Journal of Rheumatology 2009;36:254-259.
ABSTRACT
| FULL TEXT
Validity and responsiveness of the Rehabilitation Activities Profile (RAP) in patients with rheumatoid arthritis
Verhoef et al.
Clin Rehabil 2008;22:788-800.
ABSTRACT
Author Response
Rampello and Chetta
ptjournal 2007;87:558-559.
FULL TEXT
Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach
Karim et al.
Ann Rheum Dis 2007;66:690-692.
ABSTRACT
| FULL TEXT
Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years
Strand et al.
Rheumatology (Oxford) 2006;45:1505-1513.
ABSTRACT
| FULL TEXT
Prognosis in Soft Tissue Disorders of the Shoulder: Predicting Both Change in Disability and Level of Disability After Treatment
Kennedy et al.
ptjournal 2006;86:1013-1032.
ABSTRACT
| FULL TEXT
Physical Therapist Examination, Evaluation, and Intervention Following the Surgical Reconstruction of a Grade III Acromioclavicular Joint Separation
Culp and Romani
ptjournal 2006;86:857-869.
ABSTRACT
| FULL TEXT
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial
Symmons et al.
Rheumatology (Oxford) 2006;45:558-565.
ABSTRACT
| FULL TEXT
The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment
Marra et al.
Rheumatology (Oxford) 2004;43:1390-1397.
ABSTRACT
| FULL TEXT
Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues
Wolfe et al.
Ann Rheum Dis 2004;63:ii13-ii17.
ABSTRACT
| FULL TEXT
Clinically important change in quality of life in epilepsy
Wiebe et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:116-120.
ABSTRACT
| FULL TEXT
The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database
Scott and Strand
Rheumatology (Oxford) 2002;41:899-909.
ABSTRACT
| FULL TEXT
Methods to Explain the Clinical Significance of Health Status Measures
Guyatt et al.
Mayo Clin Proc. 2002;77:371-383.
ABSTRACT
Exercise can reverse quadriceps sensorimotor dysfunction that is associated with rheumatoid arthritis without exacerbating disease activity
Bearne et al.
Rheumatology (Oxford) 2002;41:157-166.
ABSTRACT
| FULL TEXT
Values for function in rheumatoid arthritis: patients, professionals, and public
Hewlett et al.
Ann Rheum Dis 2001;60:928-933.
ABSTRACT
| FULL TEXT
Clinical quality management in rheumatoid arthritis: putting theory into practice
Uitz et al.
Rheumatology (Oxford) 2000;39:542-549.
ABSTRACT
| FULL TEXT
Sensitivity Analysis and the Expected Value of Perfect Information
Felli and Hazen
Med Decis Making 1998;18:95-109.
ABSTRACT
Response criteria for clinical trials in systemic lupus erythematosus
Liang and Fortin
Lupus 1995;4:336-338.